These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 33214900)

  • 21. Changing spatiotemporal patterns for hepatitis of unspecified aetiology in China, 2004-2021: a population-based surveillance study.
    Zhao N; Guo X; Wang L; Zhou H; Gong L; Miao Z; Chen Y; Qin S; Yu Z; Liu S; Wang S
    Front Public Health; 2023; 11():1177965. PubMed ID: 37213628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiologic changes of infectious diseases in the post-SARS era in China, 2004-2018.
    Luo Y; Wu B; Xu Y; Ai L; Lv H; Wu J; Tan W
    BMC Public Health; 2023 Nov; 23(1):2171. PubMed ID: 37932712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spatial distribution of 12 class B notifiable infectious diseases in China: A retrospective study.
    Zhu B; Fu Y; Liu J; Mao Y
    PLoS One; 2018; 13(4):e0195568. PubMed ID: 29621351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Annual incidence and fatality rates of notifiable infectious diseases in southeast China from 1950 to 2022 and relationship to socioeconomic development.
    Hu J; Li W; Peng Z; Chen Z; Shi Y; Zheng Y; Liang Q; Wu Y; Liu W; Shen W; Dai Q; Zhu L; Bao C; Zhu F; Chen F
    J Glob Health; 2023 Sep; 13():04107. PubMed ID: 37681663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Surveillance on other infectious diarrheal diseases in China from 2014 to 2015].
    Zhang P; Zhang J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Apr; 38(4):424-430. PubMed ID: 28468056
    [No Abstract]   [Full Text] [Related]  

  • 26. Analysis of spatial-temporal distribution of notifiable respiratory infectious diseases in Shandong Province, China during 2005-2014.
    Li X; Chen D; Zhang Y; Xue X; Zhang S; Chen M; Liu X; Ding G
    BMC Public Health; 2021 Aug; 21(1):1597. PubMed ID: 34461855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Dramatic achievements in infectious disease prevention and treatment in China during the past 70 years].
    Yang WZ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Dec; 40(12):1493-1498. PubMed ID: 32062906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interrupted time series analysis using the ARIMA model of the impact of COVID-19 on the incidence rate of notifiable communicable diseases in China.
    Zhou Q; Hu J; Hu W; Li H; Lin GZ
    BMC Infect Dis; 2023 Jun; 23(1):375. PubMed ID: 37316780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Trend of epidemics and variation of pathogens of hand, foot and mouth disease in China: a dynamic series analysis, 2008-2017].
    Zhang J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Feb; 40(2):147-154. PubMed ID: 30744263
    [No Abstract]   [Full Text] [Related]  

  • 30. Infectious diseases in Poland in 2014.
    Sadkowska-Todys MA; Zieliński A; Czarkowski MS
    Przegl Epidemiol; 2016; 70(2):167-181. PubMed ID: 27779831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infectious diseases in Poland in 2016.
    Sadkowska-Todys M; Zieliński A; Czarkowski MP
    Przegl Epidemiol; 2018; 72(2):129-141. PubMed ID: 30111085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013.
    Johnson NB; Hayes LD; Brown K; Hoo EC; Ethier KA;
    MMWR Suppl; 2014 Oct; 63(4):3-27. PubMed ID: 25356673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The indirect impacts of nonpharmacological COVID-19 control measures on other infectious diseases in Yinchuan, Northwest China: a time series study.
    Liu W; Wang R; Li Y; Zhao S; Chen Y; Zhao Y
    BMC Public Health; 2023 Jun; 23(1):1089. PubMed ID: 37280569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The COVID-19 epidemic and other notifiable infectious diseases in China.
    Bai BK; Jiang QY; Hou J
    Microbes Infect; 2022 Feb; 24(1):104881. PubMed ID: 34419605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Epidemiological characteristics of severe cases of hand, foot, and mouth disease in China, 2008-2018].
    Ren MR; Cui JZ; Nie TR; Liu FF; Sun JL; Zhang YW; Chang ZR
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Nov; 41(11):1802-1807. PubMed ID: 33297642
    [No Abstract]   [Full Text] [Related]  

  • 36. Morbidity Analysis of the Notifiable Infectious Diseases in China, 2018.
    Dong S; Ren X; Zhang C; Geng M; Zhu Y; Shi L; Zhang L; Li Z; Wang L
    China CDC Wkly; 2019 Dec; 1(4):47-53. PubMed ID: 34594603
    [No Abstract]   [Full Text] [Related]  

  • 37. Epidemiological Trends and Hotspots of Other Infectious Diarrhea
    Chen C; Guan Z; Huang C; Jiang D; Liu X; Zhou Y; Yan D; Zhang X; Zhou Y; Ding C; Lan L; Lin Y; Wu J; Li L; Yang S
    Front Public Health; 2021; 9():679853. PubMed ID: 34368054
    [No Abstract]   [Full Text] [Related]  

  • 38. [Analysis of reported infectious diarrhea (other than cholera, dysentery, typhoid and paratyphoid) in China in 2011].
    Liu HX; Zhang J
    Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Apr; 47(4):328-32. PubMed ID: 23928638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of the COVID-19 Pandemic on the Incidence of Notifiable Infectious Diseases in China Based on SARIMA Models Between 2013 and 2021.
    Liu J; Zeng W; Zhuo C; Liu Y; Zhu L; Zou G
    J Epidemiol Glob Health; 2024 Sep; 14(3):1191-1201. PubMed ID: 39080246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trends in notifiable infectious diseases in China: implications for surveillance and population health policy.
    Zhang L; Wilson DP
    PLoS One; 2012; 7(2):e31076. PubMed ID: 22359565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.